{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2009 sorted by posted_date descending", "rows": [["FDA-2008-N-0546-0009", "FDA", "FDA-2008-N-0546", "Agency Information Collection Activities; Proposed Collection; Comment Request; Pet Food Early Warning Recall Rational Questionnaire as Part of the MedWatchPlus", "Notice", "N-Notice", "2009-12-30T05:00:00Z", 2009, 12, "2009-12-30T05:00:00Z", "2010-01-30T04:59:59Z", "2009-12-30T17:57:40Z", "E9-30872", 0, 0, "0900006480a741c2"], ["FDA-2009-N-0664-0131", "FDA", "FDA-2009-N-0664", "Medical Device Interoperability; Public Workshop", "Notice", "NM-Notice of Meeting", "2009-12-30T05:00:00Z", 2009, 12, "2009-12-30T05:00:00Z", null, "2009-12-30T17:44:57Z", "E9-30871", 0, 0, "0900006480a740cd"], ["FDA-2009-N-0664-0130", "FDA", "FDA-2009-N-0664", "Advisory Committees; Tentative Schedule of Meetings for 2010", "Notice", "N-Notice", "2009-12-30T05:00:00Z", 2009, 12, "2009-12-30T05:00:00Z", null, "2009-12-30T17:39:27Z", "E9-30973", 0, 0, "0900006480a74087"], ["FDA-2009-N-0664-0132", "FDA", "FDA-2009-N-0664", "Second Annual Sentinel Initiative Public Workshop", "Notice", "NM-Notice of Meeting", "2009-12-30T05:00:00Z", 2009, 12, "2009-12-30T05:00:00Z", null, "2009-12-30T17:49:10Z", "E9-30971", 0, 0, "0900006480a740d2"], ["FDA-2009-D-0591-0001", "FDA", "FDA-2009-D-0591", "Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions;Availability", "Notice", "NAD-Notice of Availability of Data", "2009-12-29T05:00:00Z", 2009, 12, "2009-12-29T05:00:00Z", null, "2009-12-29T14:32:34Z", "E9-30750", 0, 0, "0900006480a7313d"], ["FDA-2009-D-0600-0001", "FDA", "FDA-2009-D-0600", "Draft Guidance for Industry on Tobacco Health Document Submission; Availability", "Notice", "Notice of Availability", "2009-12-28T05:00:00Z", 2009, 12, "2009-12-28T05:00:00Z", "2010-01-23T04:59:59Z", "2016-09-09T14:32:45Z", "E9-30657", 0, 0, "0900006480a72053"], ["FDA-2009-N-0664-0129", "FDA", "FDA-2009-N-0664", "Gastrointestinal Drugs Advisory Committee Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2009-12-23T19:25:45Z", "E9-30442", 0, 0, "0900006480a704a2"], ["FDA-2008-D-0399-0006", "FDA", "FDA-2008-D-0399", "International Conference on Harmonisation: Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions  Annex 5: Disintegration Test General Chapter", "Notice", "NAD-Notice of Availability of Data", "2009-12-23T05:00:00Z", 2009, 12, "2009-12-23T05:00:00Z", null, "2009-12-23T19:06:42Z", "E9-30441", 0, 0, "0900006480a70631"], ["FDA-2009-D-0013-0004", "FDA", "FDA-2009-D-0013", "International Conference on Harmonisation: Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions", "Notice", "NAD-Notice of Availability of Data", "2009-12-22T05:00:00Z", 2009, 12, "2009-12-22T05:00:00Z", null, "2009-12-22T16:28:44Z", "E9-30326", 0, 0, "0900006480a6f728"], ["FDA-2009-D-0588-0001", "FDA", "FDA-2009-D-0588", "Guidance for Industry on the Timeframe for Submission of Tobacco Health Documents; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-12-21T05:00:00Z", 2009, 12, "2009-12-21T05:00:00Z", null, "2009-12-22T15:59:22Z", "E9-30297", 0, 0, "0900006480a6ef9e"], ["FDA-2003-M-0501-0001", "FDA", "FDA-2003-M-0501", "Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "N-Notice", "2009-12-18T05:00:00Z", 2009, 12, "2009-12-18T05:00:00Z", null, "2025-04-16T19:38:47Z", "03-27119", 0, 0, "09000064804a2b25"], ["FDA-2009-N-0575-0001", "FDA", "FDA-2009-N-0575", "Meetings: Incorporation of New Science Into Regulatory Decisionmaking Within the Center for Devices and Radiological Health", "Notice", "NM-Notice of Meeting", "2009-12-18T05:00:00Z", 2009, 12, "2009-12-18T05:00:00Z", "2010-02-25T04:59:59Z", "2009-12-18T15:14:35Z", "E9-30114", 0, 0, "0900006480a6de81"], ["FDA-2009-D-0574-0001", "FDA", "FDA-2009-D-0574", "International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions", "Notice", "NAD-Notice of Availability of Data", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", "2010-02-17T04:59:59Z", "2009-12-17T20:33:56Z", "E9-29988", 0, 0, "0900006480a6ca37"], ["FDA-2009-F-0570-0001", "FDA", "FDA-2009-F-0570", "Lallemand, Inc.; Filing of Food Additive Petition", "Notice", "NFL-Notice of Filing", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2009-12-17T19:55:48Z", "E9-29961", 0, 0, "0900006480a6c9d7"], ["FDA-2009-N-0664-0127", "FDA", "FDA-2009-N-0664", "Oncologic Drugs Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2009-12-17T19:59:52Z", "E9-29989", 0, 0, "0900006480a6ca01"], ["FDA-2009-D-0573-0001", "FDA", "FDA-2009-D-0573", "International Conference on Harmonisation; Draft Guidance on Addendum to International Conference on Harmonisation S6", "Notice", "NAD-Notice of Availability of Data", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", "2010-02-02T04:59:59Z", "2009-12-17T20:30:17Z", "E9-29991", 0, 0, "0900006480a6ca36"], ["FDA-2009-N-0665-0074", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Ractopamine; Tylosin", "Notice", "Notice of Final Rule", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2013-07-09T16:15:47Z", "E9-29998", 0, 0, "0900006480a6ca39"], ["FDA-2009-N-0664-0128", "FDA", "FDA-2009-N-0664", "Food and Drug Administration Clinical Trial Requirements, Regulations, Compliance and Good Clinical Practices; Public Workshop", "Notice", "NM-Notice of Meeting", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", null, "2009-12-17T20:10:36Z", "E9-30017", 0, 0, "0900006480a6ca05"], ["FDA-2009-D-0579-0001", "FDA", "FDA-2009-D-0579", "International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International", "Notice", "NAD-Notice of Availability of Data", "2009-12-17T05:00:00Z", 2009, 12, "2009-12-17T05:00:00Z", "2010-02-17T04:59:59Z", "2009-12-17T19:32:00Z", "E9-29990", 0, 0, "0900006480a6c715"], ["FDA-2009-N-0665-0071", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor; Ketamine - Final Rule", "Notice", "Notice of Final Rule", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2014-07-11T16:32:48Z", "E9-29888", 0, 0, "0900006480a6bb3c"], ["FDA-2009-N-0665-0072", "FDA", "FDA-2009-N-0665", "Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol", "Notice", "Notice of Final Rule", "2009-12-16T05:00:00Z", 2009, 12, "2009-12-16T05:00:00Z", null, "2013-07-09T16:24:11Z", "E9-29875", 0, 0, "0900006480a6bb82"], ["FDA-1981-D-0064-0001", "FDA", "FDA-1981-D-0064", "DEFECT ACTION LEVELS FOR HISTAMINE IN TUNA; AVAILABILITY OF GUIDE", "Notice", "Notice of Data Availability", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", null, "2026-01-30T22:34:45Z", null, 0, 0, "09000064805af3df"], ["FDA-2009-N-0293-0001", "FDA", "FDA-2009-N-0293", "Peter Xuong Lam: Debarment Order", "Notice", "N-Notice", "2009-12-14T05:00:00Z", 2009, 12, null, null, "2009-12-14T16:56:58Z", "E9-29715", 0, 0, "0900006480a6a1b2"], ["FDA-1995-D-0298-0001", "FDA", "FDA-1995-D-0298", "Notice of Availability of Data  - NAD", "Notice", "NAD-Notice of Availability of Data", "2009-12-14T05:00:00Z", 2009, 12, "2009-12-14T05:00:00Z", "1995-09-06T03:59:59Z", "2009-12-14T17:42:41Z", null, 0, 0, "09000064805998f0"], ["FDA-2009-N-0665-0067", "FDA", "FDA-2009-N-0665", "New Animal Drugs; Change of Sponsor; Azaperone", "Notice", "Notice of Final Rule", "2009-12-11T05:00:00Z", 2009, 12, "2009-12-11T05:00:00Z", null, "2013-07-09T18:17:50Z", "E9-29494", 0, 0, "0900006480a692a1"], ["FDA-2008-N-0424-0004", "FDA", "FDA-2008-N-0424", "Postmarketing Safety Reporting for Combination Products; Extension of Comment Period", "Notice", "NPR-Notice of Proposed Rule-Making", "2009-12-11T05:00:00Z", 2009, 12, "2009-12-11T05:00:00Z", "2010-01-30T04:59:59Z", "2011-06-11T16:27:47Z", "E9-29493", 0, 0, "0900006480a692a4"], ["FDA-1998-D-0025-0036", "FDA", "FDA-1998-D-0025", "Guidance on Current Good Manufacturing Practice for Positron Emission Tomography Drugs; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-12-10T05:00:00Z", 2009, 12, "2009-12-10T05:00:00Z", null, "2024-11-12T04:49:38Z", "E9-29286", 1, 0, "0900006480a6845a"], ["FDA-2004-N-0449-0003", "FDA", "FDA-2004-N-0449", "Current Good Manufacturing Practice for Positron Emission Tomography Drugs; Final Rule", "Notice", "Notice of Final Rule", "2009-12-10T05:00:00Z", 2009, 12, "2009-12-10T05:00:00Z", null, "2015-12-10T15:21:51Z", "E9-29285", 0, 0, "0900006480a6840e"], ["FDA-2009-N-0561-0001", "FDA", "FDA-2009-N-0561", "Electronic Margin of Safety and NonClinical Toxicology Study Data Submission; Notice of Pilot Project", "Notice", "N-Notice", "2009-12-10T05:00:00Z", 2009, 12, "2009-12-10T05:00:00Z", "2010-03-11T04:59:59Z", "2009-12-10T15:35:48Z", "E9-29419", 0, 0, "0900006480a684bb"], ["FDA-2006-D-0362-0005", "FDA", "FDA-2006-D-0362", "Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development To Support Labeling Claims; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", null, "2009-12-09T17:15:22Z", "E9-29273", 0, 0, "0900006480a66be8"], ["FDA-2009-N-0569-0001", "FDA", "FDA-2009-N-0569", "Approved Tobacco Retailer Training Program; Request for Comments", "Notice", "N-Notice", "2009-12-09T05:00:00Z", 2009, 12, "2009-12-09T05:00:00Z", "2010-01-09T04:59:59Z", "2010-01-20T17:06:47Z", "E9-29288", 0, 0, "0900006480a66b8a"], ["FDA-2009-N-0664-0126", "FDA", "FDA-2009-N-0664", "Meetings: Anesthetic and Life Support Drugs Advisory Committee", "Notice", "NM-Notice of Meeting", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2009-12-08T15:43:55Z", "E9-29211", 0, 0, "0900006480a66771"], ["FDA-2009-N-0664-0125", "FDA", "FDA-2009-N-0664", "Meetings: Oncologic Drugs Advisory Committee", "Notice", "N-Notice", "2009-12-08T05:00:00Z", 2009, 12, "2009-12-08T05:00:00Z", null, "2009-12-08T15:45:20Z", "E9-29208", 0, 0, "0900006480a66745"], ["FDA-2009-F-0525-0001", "FDA", "FDA-2009-F-0525", "Filing of Food Additive Petition (Animal Use) Kemira Oyj; Formic Acid", "Notice", "NFL-Notice of Filing", "2009-12-07T05:00:00Z", 2009, 12, "2009-12-07T05:00:00Z", "2010-01-07T04:59:59Z", "2009-12-07T16:23:09Z", "E9-29049", 0, 0, "0900006480a64b02"], ["FDA-2009-D-0539-0001", "FDA", "FDA-2009-D-0539", "Draft Guidance for Industry on Assay Development for Immunogenicity Testing of Therapeutic Proteins; Availability", "Notice", "Notice of Availability", "2009-12-04T05:00:00Z", 2009, 12, "2009-12-04T05:00:00Z", "2010-02-03T04:59:59Z", "2016-04-11T14:24:08Z", "E9-28960", 0, 0, "0900006480a62b67"], ["FDA-2009-D-0542-0001", "FDA", "FDA-2009-D-0542", "Draft Guidance for Industry: Factors That Distinguish Liquid Dietary Supplements From Beverages, Considerations Regarding Novel Ingredients, and Labeling for Beverages and Other Conventional Foods; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-12-04T05:00:00Z", 2009, 12, "2009-12-04T05:00:00Z", "2010-02-03T04:59:59Z", "2009-12-04T16:37:20Z", "E9-28926", 0, 0, "0900006480a62af4"], ["FDA-2008-P-0560-0004", "FDA", "FDA-2008-P-0560", "Determination That MESANTOIN (Mephenytoin) Tablets, 100 Milligrams, was not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "N-Notice", "2009-12-03T05:00:00Z", 2009, 12, "2009-12-03T05:00:00Z", null, "2009-12-03T16:23:23Z", "E9-28872", 0, 0, "0900006480a62024"], ["FDA-2008-P-0330-0004", "FDA", "FDA-2008-P-0330", "Determination That ABILIFY DISCMELT (Aripiprazole) Orally Disintegrating Tablets, 20 Milligrams and 30 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "N-Notice", "2009-12-03T05:00:00Z", 2009, 12, "2009-12-03T05:00:00Z", null, "2009-12-03T16:28:45Z", "E9-28871", 0, 0, "0900006480a6203c"], ["FDA-2009-N-0554-0001", "FDA", "FDA-2009-N-0554", "Agency Information Collection Activities; Proposed Collection; Comment Request; Manufactured Food Regulatory Program Standards", "Notice", "N-Notice", "2009-12-02T05:00:00Z", 2009, 12, "2009-12-02T05:00:00Z", "2010-02-02T04:59:59Z", "2009-12-02T20:33:26Z", "E9-28834", 0, 0, "0900006480a61db7"], ["FDA-1982-P-0018-0393", "FDA", "FDA-1982-P-0018", "Reclassify of Electroconvulsive Therapy Device", "Notice", "Notice of Intent", "2009-12-02T05:00:00Z", 2009, 12, "2009-12-02T05:00:00Z", "1983-06-07T03:59:59Z", "2024-12-17T14:01:40Z", "83-8595", 0, 0, "0900006480a61b8f"], ["FDA-1982-P-0018-0400", "FDA", "FDA-1982-P-0018", "Withdrawal of Certain Proposed Rules and Other Proposed Actions", "Notice", "Withdrawal", "2009-12-02T05:00:00Z", 2009, 12, "2009-12-02T05:00:00Z", null, "2025-01-07T16:11:00Z", "04-26234", 0, 0, "0900006480a61cb3"], ["FDA-1982-P-0018-0399", "FDA", "FDA-1982-P-0018", "Withdrawal of Certain Proposed Rules and Other Proposed Actions; Notice of Intent", "Notice", "Notice of Intent", "2009-12-02T05:00:00Z", 2009, 12, "2009-12-02T05:00:00Z", "2003-07-22T03:59:59Z", "2025-01-07T15:49:26Z", "03-9865", 0, 0, "0900006480a61caf"], ["FDA-2009-D-0466-0001", "FDA", "FDA-2009-D-0466", "Draft Compliance Policy Guide Sec. 527.300 Dairy Products-Microbial Contaminants and Alkaline Phosphatase Activity (Compliance Policy Guide 7106.08); Availability", "Notice", "NAD-Notice of Availability of Data", "2009-12-01T05:00:00Z", 2009, 12, "2009-12-01T05:00:00Z", "2010-02-02T04:59:59Z", "2009-12-01T17:53:51Z", "E9-28756", 0, 0, "0900006480a60f4f"], ["FDA-2009-D-0524-0024", "FDA", "FDA-2009-D-0524", "Guidance for Industry on Listing of Ingredients in Tobacco Products; Availability", "Notice", "Notice of Availability", "2009-12-01T05:00:00Z", 2009, 12, "2009-12-01T05:00:00Z", null, "2016-10-06T15:58:32Z", "E9-28747", 0, 0, "0900006480a60dfe"], ["FDA-2007-D-0369-0033", "FDA", "FDA-2007-D-0369", "Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-12-01T05:00:00Z", 2009, 12, "2009-12-01T05:00:00Z", "2010-02-02T04:59:59Z", "2024-11-12T04:48:26Z", "E9-28593", 1, 0, "0900006480a60ef1"], ["FDA-2009-N-0220-0009", "FDA", "FDA-2009-N-0220", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Studies of Nutrition Symbols on Food Packages", "Notice", "N-Notice", "2009-12-01T05:00:00Z", 2009, 12, null, null, "2009-12-01T17:36:23Z", "E9-28699", 0, 0, "0900006480a60eea"], ["FDA-2009-N-0664-0124", "FDA", "FDA-2009-N-0664", "Meetings: Pediatric Advisory Committee; Correction", "Notice", "NCR-Notice of Correction", "2009-11-30T05:00:00Z", 2009, 11, "2009-11-30T05:00:00Z", null, "2009-11-30T15:10:02Z", "E9-28448", 0, 0, "0900006480a6026c"], ["FDA-2009-D-0563-0001", "FDA", "FDA-2009-D-0563", "Draft Guidance for Industry and Food and Drug Administration Staff; Preliminary Timetable for the Review of Applications for Modified Risk Tobacco Products Under the Federal Food, Drug, and Cosmetic Act; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-27T05:00:00Z", 2009, 11, "2009-11-27T05:00:00Z", "2010-02-26T04:59:59Z", "2009-11-27T16:13:56Z", "E9-28515", 0, 0, "0900006480a5f56b"], ["FDA-2009-N-0664-0123", "FDA", "FDA-2009-N-0664", "Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-11-27T05:00:00Z", 2009, 11, "2009-11-27T05:00:00Z", null, "2009-11-27T15:43:51Z", "E9-28302", 0, 0, "0900006480a5f50d"], ["FDA-2008-D-0413-0015", "FDA", "FDA-2008-D-0413", "Guidance for Industry on Residual Solvents in Drug Products Marketed in the United States; Availability", "Notice", "Notice of Availability", "2009-11-25T05:00:00Z", 2009, 11, "2009-11-25T05:00:00Z", null, "2020-05-11T22:59:33Z", "E9-28247", 0, 0, "0900006480a5e954"], ["FDA-2009-N-0288-0001", "FDA", "FDA-2009-N-0288", "Anthony W. Albanese: Debarment Order", "Notice", "N-Notice", "2009-11-23T05:00:00Z", 2009, 11, null, null, "2009-11-23T15:40:25Z", "E9-28084", 0, 0, "0900006480a5c872"], ["FDA-2009-N-0281-0001", "FDA", "FDA-2009-N-0281", "Niaja Kane: Debarment Order", "Notice", "N-Notice", "2009-11-23T05:00:00Z", 2009, 11, null, null, "2009-11-23T15:45:57Z", "E9-28083", 0, 0, "0900006480a5c8d3"], ["FDA-2009-N-0556-0001", "FDA", "FDA-2009-N-0556", "Agency Information Collection Activities; Proposed Collection; Comment Request; Records and Reports Concerning Experience WithApproved New Animal Drugs", "Notice", "N-Notice", "2009-11-20T05:00:00Z", 2009, 11, "2009-11-20T05:00:00Z", "2009-12-22T04:59:59Z", "2009-11-20T15:19:13Z", "E9-27956", 0, 0, "0900006480a5b482"], ["FDA-2008-D-0614-0004", "FDA", "FDA-2008-D-0614", "Guidance for Industry on Changes to Approved New Animal Drug Applications-New Animal Drug Applications Versus Category II SupplementalNew Animal Drug Applications; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-20T05:00:00Z", 2009, 11, "2009-11-20T05:00:00Z", null, "2024-11-07T22:11:17Z", "E9-27926", 1, 0, "0900006480a5b4d9"], ["FDA-2009-N-0665-0059", "FDA", "FDA-2009-N-0665", "Oral Dosage Form New Animal Drugs; Sulfadimethoxine - Final Rule", "Notice", "Notice of Final Rule", "2009-11-20T05:00:00Z", 2009, 11, null, null, "2014-01-08T12:43:29Z", "E9-27885", 0, 0, "0900006480a5b477"], ["FDA-2009-D-0533-0001", "FDA", "FDA-2009-D-0533", "Draft Guidance for Industry: Recommendations for the Assessment of Blood Donor Suitability, Blood Product Safety, and Preservation of the Blood Supply in Response to Pandemic (H1N1) 2009 Virus; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-19T05:00:00Z", 2009, 11, "2009-11-19T05:00:00Z", "2009-12-04T04:59:59Z", "2009-11-19T15:09:58Z", "E9-27729", 0, 0, "0900006480a5ab15"], ["FDA-2009-N-0664-0121", "FDA", "FDA-2009-N-0664", "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-11-19T05:00:00Z", 2009, 11, "2009-11-19T05:00:00Z", null, "2009-11-19T15:00:23Z", "E9-27728", 0, 0, "0900006480a5aac9"], ["FDA-2009-N-0664-0122", "FDA", "FDA-2009-N-0664", "Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-11-19T05:00:00Z", 2009, 11, "2009-11-19T05:00:00Z", null, "2009-11-19T15:04:24Z", "E9-27741", 0, 0, "0900006480a5ab09"], ["FDA-2009-N-0665-0057", "FDA", "FDA-2009-N-0665", "New Animal Drugs for Use in Animal Feeds; Melengestrol; Monensin", "Notice", "Notice of Final Rule", "2009-11-19T05:00:00Z", 2009, 11, "2009-11-19T05:00:00Z", null, "2013-07-09T18:15:25Z", "E9-27744", 0, 0, "0900006480a5ab33"], ["FDA-2009-N-0143-1063", "FDA", "FDA-2009-N-0143", "Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting", "Notice", "NM-Notice of Meeting", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", "2009-11-28T04:59:59Z", "2009-11-18T17:39:41Z", "E9-27718", 0, 0, "0900006480a58ff2"], ["FDA-2009-N-0251-0003", "FDA", "FDA-2009-N-0251", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; User Fee Cover Sheet; Form FDA 3397", "Notice", "N-Notice", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", null, "2009-11-18T17:12:14Z", "E9-27719", 0, 0, "0900006480a59071"], ["FDA-2009-N-0393-0007", "FDA", "FDA-2009-N-0393", "Acrylamide in Food; Request for Comments and for Scientific Data and Information; Extension of Comment Period", "Notice", "NEC-Notice of Extension", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", "2010-01-26T04:59:59Z", "2009-11-18T19:44:04Z", "E9-27692", 0, 0, "0900006480a58fc6"], ["FDA-2009-N-0545-0001", "FDA", "FDA-2009-N-0545", "Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing; Form FDA 3486 and Addendum 3486A", "Notice", "N-Notice", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", "2010-01-20T04:59:59Z", "2009-11-18T19:42:09Z", "E9-27716", 0, 0, "0900006480a58fc5"], ["FDA-2009-N-0535-0001", "FDA", "FDA-2009-N-0535", "Agency Information Collection Activities; Proposed Collection; Comment Request; \"Real Time\" Surveys of Consumers", "Notice", "N-Notice", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", "2010-01-20T04:59:59Z", "2009-11-18T17:17:04Z", "E9-27659", 0, 0, "0900006480a59000"], ["FDA-2009-N-0291-0002", "FDA", "FDA-2009-N-0291", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Infectious Disease Issues in Xenotransplantation", "Notice", "N-Notice", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", null, "2009-11-18T19:39:06Z", "E9-27658", 0, 0, "0900006480a58ff1"], ["FDA-2009-C-0543-0001", "FDA", "FDA-2009-C-0543", "Sauflon Pharmaceuticals Ltd.; Filing of Color Additive Petition", "Notice", "NFL-Notice of Filing", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", null, "2009-11-18T17:23:15Z", "E9-27629", 0, 0, "0900006480a59037"], ["FDA-2009-N-0664-0120", "FDA", "FDA-2009-N-0664", "Anti-Infective Drugs Advisory Committee; Amendment of Notice", "Notice", "N-Notice", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", null, "2009-11-18T17:43:36Z", "E9-27693", 0, 0, "0900006480a59038"], ["FDA-2009-N-0532-0001", "FDA", "FDA-2009-N-0532", "Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Nutrition Facts Label Formats", "Notice", "N-Notice", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", "2010-01-20T04:59:59Z", "2009-11-18T19:40:46Z", "E9-27720", 0, 0, "0900006480a58fea"], ["FDA-2009-N-0667-0011", "FDA", "FDA-2009-N-0667", "Memorandum of Understanding Between the Food and Drug Administration and Waterfront Media", "Notice", "N-Notice", "2009-11-18T05:00:00Z", 2009, 11, "2009-11-18T05:00:00Z", null, "2009-11-18T17:30:45Z", "E9-27630", 0, 0, "0900006480a5904e"], ["FDA-1998-P-0974-0002", "FDA", "FDA-1998-P-0974", "FDA/CDER - AstraZencea Pharmaceuticals LP - Withdrawl", "Notice", "NWL-Notice of Withdrawl", "2009-11-17T05:00:00Z", 2009, 11, "2009-11-17T05:00:00Z", null, "2009-11-17T15:33:19Z", null, 0, 0, "09000064805a24d1"], ["FDA-1998-P-0974-0001", "FDA", "FDA-1998-P-0974", "Gensia Sicor Pharmaceutical Inc - Comment", "Notice", "N-Notice", "2009-11-17T05:00:00Z", 2009, 11, "2009-11-17T05:00:00Z", null, "2013-07-27T21:47:33Z", null, 0, 0, "09000064805a24c3"], ["FDA-2009-N-0664-0118", "FDA", "FDA-2009-N-0664", "Oncologic Drugs Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-11-17T05:00:00Z", 2009, 11, null, null, "2009-11-17T17:38:38Z", "E9-27493", 0, 0, "0900006480a593d0"], ["FDA-2009-N-0664-0119", "FDA", "FDA-2009-N-0664", "General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-11-17T05:00:00Z", 2009, 11, null, null, "2009-11-17T17:42:04Z", "E9-27491", 0, 0, "0900006480a5942c"], ["FDA-2009-N-0664-0117", "FDA", "FDA-2009-N-0664", "Oncologic Drugs Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-11-17T05:00:00Z", 2009, 11, null, null, "2009-11-17T17:35:10Z", "E9-27490", 0, 0, "0900006480a593f6"], ["FDA-2009-N-0083-0012", "FDA", "FDA-2009-N-0083", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Gluten-Free Labeling of Food Products Experimental Study", "Notice", "N-Notice", "2009-11-17T05:00:00Z", 2009, 11, null, null, "2009-11-17T17:30:25Z", "E9-27512", 0, 0, "0900006480a593b2"], ["FDA-2009-N-0664-0115", "FDA", "FDA-2009-N-0664", "Thermal Aspects of Radio Frequency Exposure; Public Workshop", "Notice", "NM-Notice of Meeting", "2009-11-17T05:00:00Z", 2009, 11, null, null, "2009-11-17T17:19:46Z", "E9-27513", 0, 0, "0900006480a59359"], ["FDA-2009-N-0664-0116", "FDA", "FDA-2009-N-0664", "National Mammography Quality Assurance Advisory Committee; Notice of Meeting", "Notice", "NM-Notice of Meeting", "2009-11-17T05:00:00Z", 2009, 11, null, null, "2009-11-17T17:23:57Z", "E9-27492", 0, 0, "0900006480a5937c"], ["FDA-2000-D-1542-0001", "FDA", "FDA-2000-D-1542", "Draft Guidance for Industry on the Content and Format of New Drug Applications and Abbreviated New Drug Applications for Certain Positron Emission Tomography Drug Products; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-16T05:00:00Z", 2009, 11, "2009-11-16T05:00:00Z", "2000-06-09T03:59:59Z", "2009-11-16T19:37:14Z", null, 0, 0, "09000064804f9074"], ["FDA-1998-N-0872-0001", "FDA", "FDA-1998-N-0872", "Import for Export; Reporting and Recordkeeping Requirements for Unapproved or Violative Products Imported for Further Processing or Incorporation and Subsequent Export", "Notice", "Proposed Guidelines", "2009-11-13T05:00:00Z", 2009, 11, "1998-11-24T05:00:00Z", "1999-02-09T04:59:59Z", "2024-10-03T12:52:58Z", "98-31351", 0, 0, "09000064805a13c0"], ["FDA-2008-N-0488-0025", "FDA", "FDA-2008-N-0488", "Medical Devices: Ophthalmic Devices; Laser-Assisted In Situ Keratomileusis (LASIK) Devices; Reopening of the Comment Period", "Notice", "N-Notice", "2009-11-13T05:00:00Z", 2009, 11, "2009-11-13T05:00:00Z", "2010-11-16T04:59:59Z", "2009-11-13T15:03:26Z", "E9-27222", 0, 0, "0900006480a56cc2"], ["FDA-2009-N-0292-0001", "FDA", "FDA-2009-N-0292", "Michelle Lynn Torgerson; Debarment Order", "Notice", "N-Notice", "2009-11-13T05:00:00Z", 2009, 11, "2009-11-13T05:00:00Z", null, "2009-11-13T14:57:59Z", "E9-27223", 0, 0, "0900006480a56c08"], ["FDA-1998-N-0872-0002", "FDA", "FDA-1998-N-0872", "Import for Export; Reporting and Recordkeeping Requirements for Unapproved or Violative Products Imported for Further Processing or Incorporation and Subsequent Export; Marking Requirements for and Prohibitions on the Reimportation of Imported Food Products That Have Been Refused Admission Into the United States; Withdrawal", "Notice", "Withdrawal", "2009-11-13T05:00:00Z", 2009, 11, null, null, "2024-09-25T12:53:51Z", "02-21264", 0, 0, "09000064805a13ea"], ["FDA-1998-D-0544-0001", "FDA", "FDA-1998-D-0544", "Draft Modifications to Devices Subject to Premarket Approval - The PMA Supplement Decision Making Process; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-12T05:00:00Z", 2009, 11, "2009-11-12T05:00:00Z", "1998-11-05T04:59:59Z", "2009-11-12T23:09:55Z", null, 0, 0, "090000648059b513"], ["FDA-2009-D-0508-0009", "FDA", "FDA-2009-D-0508", "Guidance for Industry on Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments; Availability", "Notice", "Notice of Availability", "2009-11-12T05:00:00Z", 2009, 11, "2009-11-12T05:00:00Z", null, "2024-11-07T22:12:04Z", "E9-27182", 1, 0, "0900006480a55f9e"], ["FDA-1989-E-0386-0001", "FDA", "FDA-1989-E-0386", "Determination of Regulatory Review Period for Purposes of Patent Extenion; Cytovene", "Notice", "N-Notice", "2009-11-12T05:00:00Z", 2009, 11, "2009-11-12T05:00:00Z", "1989-11-28T04:59:59Z", "2009-11-12T22:48:06Z", null, 0, 0, "090000648047a47c"], ["FDA-2009-D-0528-0001", "FDA", "FDA-2009-D-0528", "International Conference on Harmonisation; Draft Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-10T05:00:00Z", 2009, 11, "2009-11-10T05:00:00Z", "2010-01-12T04:59:59Z", "2009-11-10T17:26:33Z", "E9-27000", 0, 0, "0900006480a54e55"], ["FDA-2009-N-0667-0009", "FDA", "FDA-2009-N-0667", "Memorandum of Understanding Between the Food and Drug Administration, United States Department of Health and Human Services and the National Oceanic and Atmospheric Administration, United States Department of Commerce", "Notice", "N-Notice", "2009-11-10T05:00:00Z", 2009, 11, null, null, "2009-11-10T17:42:24Z", "E9-27118", 0, 0, "0900006480a54f06"], ["FDA-2008-D-0233-0029", "FDA", "FDA-2008-D-0233", "Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-09T05:00:00Z", 2009, 11, "2009-11-09T05:00:00Z", null, "2009-11-09T17:00:09Z", "E9-26870", 0, 0, "0900006480a53fe0"], ["FDA-2009-N-0506-0001", "FDA", "FDA-2009-N-0506", "Agency Information Collection Activities; Proposed Collection; Comment Request; Bar Code Label Requirement for Human Drug and Biological Products", "Notice", "N-Notice", "2009-11-06T05:00:00Z", 2009, 11, "2009-11-06T05:00:00Z", "2010-01-06T04:59:59Z", "2009-11-06T17:06:28Z", "E9-26850", 0, 0, "0900006480a52a09"], ["FDA-2009-D-0319-0001", "FDA", "FDA-2009-D-0319", "Guidance for Industry and Food and Drug Administration Staff; In Vitro Diagnostic 2009 H1N1 Tests for Use in the 2009 H1N1 Emergency; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-06T05:00:00Z", 2009, 11, "2009-11-06T05:00:00Z", null, "2009-11-06T17:16:29Z", "E9-26737", 0, 0, "0900006480a52aac"], ["FDA-2009-N-0507-0001", "FDA", "FDA-2009-N-0507", "Agency Information Collection Activities: Proposed Collection; Comment Request; Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format", "Notice", "N-Notice", "2009-11-06T05:00:00Z", 2009, 11, "2009-11-06T05:00:00Z", "2010-01-06T04:59:59Z", "2009-11-06T17:11:19Z", "E9-26760", 0, 0, "0900006480a517ab"], ["FDA-2009-D-0322-0001", "FDA", "FDA-2009-D-0322", "Draft Guidance for Industry on Dosage Delivery Devices for Over-The-Counter Liquid Drug Products; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-11-05T05:00:00Z", 2009, 11, "2009-11-05T05:00:00Z", "2010-02-04T04:59:59Z", "2009-11-05T15:22:21Z", "E9-26531", 0, 0, "0900006480a5173f"], ["FDA-2009-N-0526-0001", "FDA", "FDA-2009-N-0526", "Safe Use Initiative; Availability of Information", "Notice", "N-Notice", "2009-11-05T05:00:00Z", 2009, 11, "2009-11-05T05:00:00Z", null, "2024-11-07T22:08:15Z", "E9-26530", 1, 0, "0900006480a517a4"], ["FDA-2009-N-0667-0007", "FDA", "FDA-2009-N-0667", "Amendment to Memorandum of Understanding Between the Food and Drug Administration and WebMD, LLC", "Notice", "N-Notice", "2009-11-05T05:00:00Z", 2009, 11, "2009-11-05T05:00:00Z", null, "2009-11-05T15:37:38Z", "E9-26674", 0, 0, "0900006480a51786"], ["FDA-2007-C-0044-0003", "FDA", "FDA-2007-C-0044", "Listing of Color Additives Exempt From Certification; Astaxanthin Dimethyldisuccinate", "Notice", "NFR-Notice of Final Rule", "2009-11-05T05:00:00Z", 2009, 11, "2009-11-05T05:00:00Z", "2009-12-08T04:59:59Z", "2026-01-08T20:58:38Z", "E9-26524", 0, 0, "0900006480a51773"], ["FDA-2009-D-0347-0010", "FDA", "FDA-2009-D-0347", "Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Melons; Extension of Comment Period", "Notice", "NEC-Notice of Extension", "2009-11-04T05:00:00Z", 2009, 11, "2009-11-04T05:00:00Z", "2010-01-05T04:59:59Z", "2009-11-04T15:37:25Z", "E9-26638", 0, 0, "0900006480a503a9"], ["FDA-2009-D-0346-0013", "FDA", "FDA-2009-D-0346", "Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Tomatoes; Extension of Comment Period", "Notice", "Extension of Comment Period", "2009-11-04T05:00:00Z", 2009, 11, "2009-11-04T05:00:00Z", "2010-01-05T04:59:59Z", "2019-02-28T14:03:35Z", "E9-26636", 0, 0, "0900006480a503a3"], ["FDA-2009-D-0348-0014", "FDA", "FDA-2009-D-0348", "Draft Guidance for Industry: Guide to Minimize Microbial Food Safety Hazards of Leafy Greens; Extension of Comment Period", "Notice", "NEC-Notice of Extension", "2009-11-04T05:00:00Z", 2009, 11, "2009-11-04T05:00:00Z", "2010-01-05T04:59:59Z", "2009-11-04T15:39:48Z", "E9-26637", 0, 0, "0900006480a503f7"], ["FDA-2009-N-0519-0001", "FDA", "FDA-2009-N-0519", "Public Workshop: International Conference on Harmonisation S2 Genetic Toxicology Issues; Request for Comments", "Notice", "NM-Notice of Meeting", "2009-11-03T05:00:00Z", 2009, 11, "2009-11-03T05:00:00Z", "2010-02-25T04:59:59Z", "2009-11-03T18:30:17Z", "E9-26397", 0, 0, "0900006480a4fe9e"], ["FDA-2009-N-0523-0001", "FDA", "FDA-2009-N-0523", "Product Tracing Systems for Food; Public Meeting", "Notice", "NM-Notice of Meeting", "2009-11-03T05:00:00Z", 2009, 11, "2009-11-03T05:00:00Z", "2010-03-05T04:59:59Z", "2010-03-04T22:10:42Z", "E9-26479", 0, 0, "0900006480a4fe7a"]], "truncated": false, "filtered_table_rows_count": 735, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2009"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009", "results": [{"value": "FDA", "label": "FDA", "count": 735, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2009", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009", "results": [{"value": "Notice", "label": "Notice", "count": 735, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2009", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009", "results": [{"value": 2009, "label": 2009, "count": 735, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009&_facet_date=last_modified"}], "next": "2009-11-03T05~3A00~3A00Z,FDA-2009-N-0523-0001", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2009&_next=2009-11-03T05~3A00~3A00Z%2CFDA-2009-N-0523-0001&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1019.1980840172619, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}